To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
7 Newest Market Studies
rss
Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review
Medivir AB (Medivir) is a pharmaceuticals company. It undertakes the research and development of drugs for high-value treatments of infectious diseases. The company operates through two business...
Medivir AB – Product Pipeline Review – 2012
Introduction Global Market Direct’s pharmaceuticals report, “Medivir AB - Product Pipeline Review - 2012” provides data on the Medivir AB’s research and development focus. The report includes...
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
., Ltd., Chongqing Jiachen Biotechnology Ltd, Chongqing Tongjunge Co., Ltd., LG Life Sciences, Ltd, Bristol-Myers Squibb Company, Phytrix Inc., Medivir AB, AiCuris GmbH & Co. KG, Gilead Sciences, Inc...
Medivir AB (MEDIVIR AB) - Financial and Strategic SWOT Analysis Review
Medivir AB (Medivir) is a pharmaceuticals company engaged in the research and development of drugs for high-value treatments of infectious diseases. The company operates through two business segments...
Sweden Pharmaceuticals and Healthcare Report Q3 2011
partnered. ?? In the same month, Sweden-based pharmaceutical research company Medivir reached a partnership agreement with US pharmaceutical firm Johnson & Johnson’s unit Janssen Pharmaceutica...
BioPhausia AB (BIOP) - Financial and Strategic SWOT Analysis Review
with arthritic joint disorders; Mollipect is indicated for the treatment of cough. BioPhausia is headquartered Stockholm, Sweden. Recently, Medivir AB announced its plans to acquire 100% stake in BioPhausia AB...
Medivir AB (MVIRB) - Financial and Strategic SWOT Analysis Review
Medivir AB (Medivir) is a research focused pharmaceuticals company engaged in the development of drugs against widespread diseases such as hepatitis C, with proteases as its target enzyme...
Page 1 From 1
Netmeeting
